These new drugs might never get a chance to save the U.S. $250 billion
July 20, 2016 at 09:44 AM EDT
Biosimilars are often compared with generics, which have upended drug pricing over the last three decades.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.